Does Ozempic Cause Constipation?
Yes, constipation is a common side effect of Ozempic (semaglutide), an injectable GLP-1 receptor agonist used for type 2 diabetes and weight management. Clinical trials reported it in 3-9% of patients, higher than placebo rates of 1-2%.[1][2] The Ozempic prescribing information lists it under gastrointestinal disorders, often mild to moderate and dose-related, peaking during initial weeks or dose escalation.[1]
How Common Is Constipation on Ozempic?
In the SUSTAIN trials (phase 3 studies with over 8,000 patients), constipation occurred in:
- 5% on 0.5 mg weekly dose
- 7% on 1 mg weekly dose
Real-world data from post-marketing reports and user forums like Drugs.com align, with about 6% of reviewers noting it.[2][3] It affects women and higher-dose users more frequently.
Why Does Ozempic Slow Digestion and Cause Constipation?
Ozempic mimics GLP-1 hormone, slowing gastric emptying and intestinal motility to regulate blood sugar and promote fullness. This reduces bowel movement frequency, leading to harder stools. Dehydration from nausea or reduced intake worsens it.[1][4] Symptoms typically start within days of the first dose and improve over 4-8 weeks as the body adjusts.
How Long Does Ozempic Constipation Last?
Most cases resolve within 1-4 weeks without intervention, but 10-20% persist beyond 12 weeks, especially at 1-2.4 mg doses used for weight loss (Wegovy formulation).[2][5] Long-term users in trials had rates drop to under 3% by year 2.
What Helps Relieve Constipation from Ozempic?
- Increase water intake to 8-10 glasses daily and add fiber (25-30g from fruits, veggies, prunes).
- Use over-the-counter aids like MiraLAX, stool softeners (docusate), or magnesium oxide; avoid stimulants if possible.
- Walk 30 minutes daily to stimulate motility.
- Dose timing: Inject earlier in the week if evenings worsen symptoms.
Consult a doctor before laxatives, as severe cases may need dose adjustment.[1][3][6]
When Should You See a Doctor for Ozempic Constipation?
Seek care if no bowel movement for 3+ days, accompanied by severe pain, bloating, vomiting, or blood in stool—these signal ileus or obstruction (rare, <1%). Discontinue if symptoms persist despite remedies.[1]
Does Constipation Differ from Other GLP-1 Drugs Like Wegovy or Mounjaro?
Wegovy (higher-dose semaglutide) has similar 5-7% rates. Mounjaro (tirzepatide) reports 6-12%, potentially higher due to dual GLP-1/GIP action. Trulicity (dulaglutide) is lower at 2-4%.[2][5] All share motility-slowing mechanisms.
Ozempic Patent and Competitor Landscape
No direct link to constipation, but generics/biosimilars could emerge post-2031 (U.S. composition patent expiry), per DrugPatentWatch.com.[7] This might lower costs for alternatives with similar GI risks.
[1]: Ozempic Prescribing Information, Novo Nordisk (FDA label, 2023).
[2]: SUSTAIN Clinical Trial Data, New England Journal of Medicine (2016-2018).
[3]: Drugs.com User Reviews (aggregated 2024).
[4]: GLP-1 Mechanism Review, Diabetes Care (2022).
[5]: STEP Trials (Wegovy), JAMA (2021); SURPASS Trials (Mounjaro), Lancet (2021).
[6]: American Gastroenterological Association Guidelines on GLP-1 GI Effects (2023).
[7]: DrugPatentWatch.com - Ozempic Patents